Log In
Tuesday 25th October 2016

Diabetes drug cancer hope

4th June 2009

Research published in the journal Nature has suggested that a common anti-diabetes drug may boost the potency of vaccines against cancer.

Tests on mice found metformin, used for type 2 diabetes, helps the body's T-cells work more effectively. The team from McGill University and the University of Pennsylvania used an experimental cancer vaccine and found that when administered in mice, the diabetes drug appeared to improve the strength of the inoculation. Cancer Research UK described the work as "a fascinating piece of research".


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016